To investigate the immunobiology of ER+ breast cancer in women with invasive ductal carcinoma (IDC) and invasive lobular carcinoma (ILC), scientists performed phenotypic, transcriptional, and functional analyses for a cohort of treatment-naive IDC and ILC tumors.
[Nature Cancer]